Lehman David Aaron's Form 4 filing
Pulmonx Corp (LUNG) · filed Dec 4, 2024
- Accession no.
- 0001415889-24-028318
- Filed
- Dec 4, 2024
- Trade date
- Dec 2, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $34.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lehman David AaronCIK 0001354228 | Officer (GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Common Stock | SSaleDisposed | −410 | $6.18 | −$2,533.8 | 202,938 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −722 | $6.19 | −$4,469.18 | 202,216 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −2,755 | $6.19 | −$17,053.45 | 199,461 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −1,610 | $6.18 | −$9,949.8 | 197,851 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.